Zyneyro ApS

CVR 42057428 · Private limited company (ApS) · Active · Medium risk

Zyneyro ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 4.1m and a net result of DKK -7.5m. CEO: Steen Søren Klysner.

Bankruptcy risk for Zyneyro ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 77% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Registered owners4+ · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42057428
Status
Active
Company type
Private limited company (ApS)
Founded
(5 years)
Address
Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 53k
Auditor
Sønderup Godkendt Revisionsaktieselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 5
Missing annual reportNo
Negative equityNo
Equity ratio78.7%
Current ratio456%
Moves (last 2 years)2
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address167
Going-concern uncertaintyYes

Financials and key figures

Financial year20252024
Gross profitDKK -4.6mDKK 4.2m
Net profitDKK -7.5mDKK 666k
EquityDKK 4.1mDKK 614k
Total assetsDKK 5.3mDKK 1.4m
CashDKK 3.1m–
Short-term debtDKK 1.1m–
Tax owedDKK 0–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Sønderup Godkendt Revisionsaktieselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025110
1 Jan 2024 – 31 Dec 2024136
1 Jan 2023 – 31 Dec 2023169
1 Jan 2022 – 31 Dec 2022171
26 Jan 2021 – 31 Dec 2021166

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOSteen Søren KlysnerCurrent
CEOPeter Horn Møller
BoardJacob ØrndrupCurrent
BoardAndreas Toft SørensenCurrent
BoardUlrik GetherCurrent
BoardKenneth Lindegaard MadsenCurrent
BoardErik VintherCurrent
BoardPeter Horn Møller
Owner (15%)Marigold Innovation ApSCurrent
Owner (15%)IFO ApSCurrent
Owner (15%)UGether ApSCurrent
Owner (15%)KLMBio ApSCurrent
Owner (20%)Marigold Maturation Fund K/SCurrent
Owner (15%)Marigold Innovation ApS
Owner (25%)IFO ApS
Owner (25%)UGether ApS
Owner (25%)KLMBio ApS
Owner (25%)Marigold Innovation ApS
Owner (25%)IFO ApS
Owner (25%)UGether ApS
Owner (25%)KLMBio ApS
Owner (20%)Marigold Innovation ApS
Owner (20%)IFO ApS
Owner (20%)UGether ApS
Owner (20%)KLMBio ApS
Owner (5%)Marigold Maturation Fund K/S
Owner (15%)Marigold Maturation Fund K/S
AuditorCity Administration II ApS
AuditorSønderup I/S, statsautoriserede revisorer
FounderMarigold Innovation ApSCurrent
FounderIFO ApSCurrent
FounderUGether ApSCurrent
FounderKLMBio ApSCurrent

The CEOs' other companies

Steen Søren Klysner – 3 other companies

Peter Horn Møller – 7 other companies

Address history (2 moves)

Ole Maaløes Vej 3, 2200 København N
c/o Marigold Innovation ApS, Ole Maaløes Vej 3, 2200 København N
Agern Alle 24, 2970 Hørsholm

Former names

Zyneyro ApS – now
DolorestBio ApS –

Other companies at the same address

Similar companies in København

Questions and answers about Zyneyro ApS

Has Zyneyro ApS gone bankrupt?

No, Zyneyro ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Zyneyro ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the CEO of Zyneyro ApS?

Steen Søren Klysner is the CEO of Zyneyro ApS.

Who is the auditor of Zyneyro ApS?

Zyneyro ApS most recently used Sønderup Godkendt Revisionsaktieselskab.

When was Zyneyro ApS founded?

Zyneyro ApS was founded on 26 January 2021.

What is the equity of Zyneyro ApS?

Equity was DKK 4.1m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.